Abstract
The nervous and immune systems collaborate in the control of homeostasis and host defence. All divisions of the nervous system, sympathetic, parasympathetic and sensory, act to regulate immune cell function. Processes under neuronal control include antigen processing and presentation, Th1/Th2 balance, immunoglobulin production and antigen specific responses, while involvement of the central nervous system allows for behavioral changes leading to avoidance of antigen or noxious stimuli. It therefore follows that dysregulation of these complex bidirectional neuroimmune signaling systems may contribute to the aetiology and pathophysiology of immune disorders including atopic disease.
A greater understanding on how the brain perceives, processes and responds to immune challenges and how multiple neurotransmitters interact to maintain or skew the balance between tolerance and immunity will undoubtedly provide opportunities for the development of novel therapeutics. Furthermore, the implications for atopic disease of relatively recent developments such as the cholinergic antiinflammatory pathway and the potential direct antigen-specific activation of the nervous system require further exploration.
Keywords: Inflammation, brain, sympathetic nervous system, vagus, neuropeptides
Current Pharmaceutical Design
Title:The Nervous System as a Critical Regulator of Immune Responses Underlying Allergy
Volume: 18 Issue: 16
Author(s): Paul Forsythe
Affiliation:
Keywords: Inflammation, brain, sympathetic nervous system, vagus, neuropeptides
Abstract: The nervous and immune systems collaborate in the control of homeostasis and host defence. All divisions of the nervous system, sympathetic, parasympathetic and sensory, act to regulate immune cell function. Processes under neuronal control include antigen processing and presentation, Th1/Th2 balance, immunoglobulin production and antigen specific responses, while involvement of the central nervous system allows for behavioral changes leading to avoidance of antigen or noxious stimuli. It therefore follows that dysregulation of these complex bidirectional neuroimmune signaling systems may contribute to the aetiology and pathophysiology of immune disorders including atopic disease.
A greater understanding on how the brain perceives, processes and responds to immune challenges and how multiple neurotransmitters interact to maintain or skew the balance between tolerance and immunity will undoubtedly provide opportunities for the development of novel therapeutics. Furthermore, the implications for atopic disease of relatively recent developments such as the cholinergic antiinflammatory pathway and the potential direct antigen-specific activation of the nervous system require further exploration.
Export Options
About this article
Cite this article as:
Forsythe Paul, The Nervous System as a Critical Regulator of Immune Responses Underlying Allergy, Current Pharmaceutical Design 2012; 18 (16) . https://dx.doi.org/10.2174/138161212800165951
DOI https://dx.doi.org/10.2174/138161212800165951 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
<i>In Vitro</i> Characteristics of Glioma Cells Targeting by OX26-modified Liposomal Cisplatin
Letters in Drug Design & Discovery Editorial [Is Drug Safety Dangerous?]
Current Drug Safety Nitrergic Response to Clostridium perfringens Infection in the Rat Brain Regions Effect of Red Light Irradiation
Central Nervous System Agents in Medicinal Chemistry Gene Therapy for Pituitary Tumors
Current Gene Therapy Molecular Targets of Tannic Acid in Alzheimer's Disease
Current Alzheimer Research Comparative Antimicrobial Activity of Ceftazidime, Tobramycin and their Novel Fixed Dose Combination in Some Pathogenic Microorganisms
Current Drug Therapy Central Nervous System Manifestations in Systemic Lupus Erythematosus
Current Rheumatology Reviews Oestradiol Signalling in the Hippocampus
Current Neuropharmacology Taking Advantage of Viral Immune Evasion: Virus-Derived Proteins Represent Novel Biopharmaceuticals
Current Medicinal Chemistry CGRP Receptor Antagonism and Migraine Therapy
Current Protein & Peptide Science Optimization of Drug Safety Profile in Inflammatory Bowel Disease Through a Personalized Approach
Current Drug Targets Editorial: [Hot Topic: Central Nervous System Drugs in the Treatment of Neurological Disorders]
Central Nervous System Agents in Medicinal Chemistry An Overview on Bacteriophages: A Natural Nanostructured Antibacterial Agent
Current Drug Delivery Systematic Review and Meta-analysis of Carbapenem Resistance of Acinetobacter baumannii in Iran
Infectious Disorders - Drug Targets Properties of a Putative Cambialistic Superoxide Dismutase from the Aerotolerant Bacterium Streptococcus thermophilus Strain LMG 18311
Protein & Peptide Letters The Origin of Lentivirus Research: Maedi-Visna Virus
Current HIV Research Modern 3D Printing Technologies: Future Trends and Developments
Recent Patents on Engineering Caenorhabditis elegans: A Model for Studying Human Pathogen Biology
Recent Patents on Biotechnology How to Manage the Infectious Risk under Anti-TNF in Inflammatory Bowel Disease
Current Drug Targets Editorial [Hot topic:Targeted Alpha Particle Therapy (Guest Editors: Ganesan Vaidyanathan and Roy Larsen)]
Current Radiopharmaceuticals